Sections Figures References Abstract Introduction Results Discussion Methods Data availability Code availability References Acknowledgements Author information Ethics declarations Additional information Supplementary information Rights and permissions About this article Advertisementnpj...
Surveillance, Epidemiology, and End Results Program [Internet]. Bethesda (MD): National Cancer Institute; [cited 8 Nov 2019]; [about 2 screens]. Available from: seer.cancer.gov. 5. United States House of Representatives. Office of the Law Revision Council, United States Code. National Cancer...
Gong, J.; Chehrazi-Raffle, A.; Reddi, S.; Salgia, R. Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: A comprehensive review of registration trials and future considerations. J. Immunother. Cancer 2018, 6, 8. [Google Scholar] [CrossRef] [PubMed] Syed, ...